As of Sep 26
| -0.08 / -6.40%|
The 3 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 2.50, with a high estimate of 5.00 and a low estimate of 1.00. The median estimate represents a +113.68% increase from the last price of 1.17.
The current consensus among 4 polled investment analysts is to Buy stock in Catalyst Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.